IBRX
Price
$2.25
Change
-$0.03 (-1.32%)
Updated
Aug 20, 04:59 PM (EDT)
Capitalization
2.14B
78 days until earnings call
NRIX
Price
$9.52
Change
-$0.32 (-3.25%)
Updated
Aug 20, 04:59 PM (EDT)
Capitalization
728.56M
49 days until earnings call
Interact to see
Advertisement

IBRX vs NRIX

Header iconIBRX vs NRIX Comparison
Open Charts IBRX vs NRIXBanner chart's image
ImmunityBio
Price$2.25
Change-$0.03 (-1.32%)
Volume$77.08K
Capitalization2.14B
Nurix Therapeutics
Price$9.52
Change-$0.32 (-3.25%)
Volume$19.06K
Capitalization728.56M
IBRX vs NRIX Comparison Chart in %
Loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBRX vs. NRIX commentary
Aug 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBRX is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 21, 2025
Stock price -- (IBRX: $2.28 vs. NRIX: $9.84)
Brand notoriety: IBRX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBRX: 126% vs. NRIX: 88%
Market capitalization -- IBRX: $2.14B vs. NRIX: $728.56M
IBRX [@Biotechnology] is valued at $2.14B. NRIX’s [@Biotechnology] market capitalization is $728.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.11B to $0. The average market capitalization across the [@Biotechnology] industry is $1.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • IBRX’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBRX’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • IBRX’s TA Score: 3 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than IBRX.

Price Growth

IBRX (@Biotechnology) experienced а -7.69% price change this week, while NRIX (@Biotechnology) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.01%. For the same industry, the average monthly price growth was +16.14%, and the average quarterly price growth was +22.21%.

Reported Earning Dates

IBRX is expected to report earnings on Nov 07, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (-0.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.14B) has a higher market cap than NRIX($729M). IBRX YTD gains are higher at: -10.937 vs. NRIX (-47.771). NRIX has higher annual earnings (EBITDA): -212.78M vs. IBRX (-237.93M). NRIX has more cash in the bank: 486M vs. IBRX (154M). NRIX has less debt than IBRX: NRIX (51.9M) vs IBRX (535M). NRIX has higher revenues than IBRX: NRIX (88.4M) vs IBRX (56.6M).
IBRXNRIXIBRX / NRIX
Capitalization2.14B729M293%
EBITDA-237.93M-212.78M112%
Gain YTD-10.937-47.77123%
P/E RatioN/AN/A-
Revenue56.6M88.4M64%
Total Cash154M486M32%
Total Debt535M51.9M1,031%
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IBRXNRIX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 7 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEOPX25.140.17
+0.68%
Davenport Equity Opportunities
GSBCX25.780.03
+0.12%
Goldman Sachs Income Builder C
LGIEX21.47-0.02
-0.09%
Franklin International Equity I
CGVBX26.56-0.08
-0.30%
American Funds Global Insight 529-C
LGPSX38.94-0.50
-1.27%
ProFunds Large Cap Growth Svc

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with CLRB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
-6.17%
CLRB - IBRX
41%
Loosely correlated
-4.26%
RXRX - IBRX
40%
Loosely correlated
-7.79%
VRDN - IBRX
39%
Loosely correlated
-1.66%
NRIX - IBRX
38%
Loosely correlated
-3.58%
QTTB - IBRX
38%
Loosely correlated
-11.27%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-3.58%
KYMR - NRIX
68%
Closely correlated
-2.41%
IDYA - NRIX
61%
Loosely correlated
-2.83%
DNLI - NRIX
58%
Loosely correlated
-0.10%
CRNX - NRIX
56%
Loosely correlated
-1.04%
BEAM - NRIX
55%
Loosely correlated
-4.39%
More